Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

Citation
Y. Tsubouchi et al., Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis, BIOC BIOP R, 270(2), 2000, pp. 400-405
Citations number
41
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
270
Issue
2
Year of publication
2000
Pages
400 - 405
Database
ISI
SICI code
0006-291X(20000413)270:2<400:IOHLCC>2.0.ZU;2-2
Abstract
Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptors superfamily, have an important regulatory role in adipog enesis and inflammation. PPAR-gamma Ligands induce terminal differentiation and growth inhibition of human breast cancer cells and prostatic cancer ce lls. In this study, we demonstrated that PPAR-gamma, but not PPAR-alpha, wa s expressed in human lung cancer cell lines by reverse transcription-polyme rase chain reaction (RT-PCR) and Western blot analysis. We also found that the synthetic PPAR-gamma agonist thiazolidinedione compounds (troglitazone) and the endogenous PPAR-gamma hgand, 15-deoxy-Delta(12,14)-prostaglandin J (2) (15d-PGJ(2)), inhibited the growth of human lung cancer cells through t he induction of apoptosis. However, PPAR-alpha agonist (bezafibrate) and ot her prostanoids (PGE(2), PGF(2 alpha)) did not induce apoptosis. These find ings suggest that PPAR-gamma may play an important role in the pathogenesis of lung cancer and that PPAR-gamma agonist may be useful therapeutic agent s in the treatment of human lung cancer. (C) 2000 Academic Press.